New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Check-Cap Ltd.
CHEK
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

8M

Medical - Diagnostics & Research

Next Earning date - 25 Nov 2024

8M

Medical - Diagnostics & Research

Next Earning date - 25 Nov 2024

1.43USD
Shape0.02 ( 1.42%)
favorite-chart

Relative Strenght

86
favorite-chart

Volume Buzz

198%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

64%

Quote Panel

Shape
Updated October 5, 2024
1W 13.49 % 1M -23.12 % 3M -26.29 % 1Y -59.94 %

Key Metrics

Shape
  • Market Cap

    8.37M


  • Shares Outstanding

    5.85M


  • Share in Float

    4.38M


  • Dividende

    0


  • Earning Date

    25 Nov 2024


  • Price Target

    1.43


  • Average Volume

    10115


  • Beta

    0.159


  • Range

    1.13-3.937


  • Industry

    Medical - Diagnostics & Research


  • Website

    https://www.check-cap.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.00x

P/S Ratio

0.35x

P/B Ratio

0.0

Debt/Equity

0.0%

Net Margin

$-3.0

EPS

How CHEK compares to sector?

P/E Ratio

Relative Strength

Shape

CHEK

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$2M

Shape-97%

2025-Revenue

$2.25

Shape10%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

N/A

-1.20
vs -1.00

Q2.22

arrow
arrow

N/A

-0.80
vs -1.20

Q3.22

arrow
arrow

N/A

-0.04
vs -0.80

Q4.22

arrow
arrow

N/A

-0.64
vs -1.14

Q1.23

arrow
arrow

N/A

-0.76
vs -1.20

Q2.23

arrow
arrow

N/A

-0.95
vs -0.80

Q3.23

arrow
arrow

N/A

-0.44
vs -0.04

Q4.23

arrow
arrow

N/A

-0.64
vs -0.64

Q1.24

arrow
arrow

N/A

-0.17
vs -0.76

Q2.24

arrow
arrow

N/A

-0.17
vs -0.95

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.21

arrow
arrow

NA

NA  vs NA

Q4.21

arrow
arrow

NA

NA  vs NA

Q1.22

arrow
arrow

NA

76K  vs NA

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

-100%

NA  vs 76K

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q1.22

arrow
arrow

-11%

-0.11
vs -0.11

Q2.22

arrow
arrow

-10%

-0.10
vs -0.11

Q3.22

arrow
arrow

-10%

-0.10
vs -0.10

Q4.22

arrow
arrow

-10%

-0.10
vs -0.10

Q1.23

arrow
arrow

-11%

-0.11
vs -0.10

Q2.23

arrow
arrow

-23%

-0.23
vs -0.11

Q3.23

arrow
arrow

-9%

-0.09
vs -0.23

Q4.23

arrow
arrow

-15%

-0.15
vs -0.09

Institutionnal OwnershipShape

status-upQoQ

Q1.21

arrow
arrow

25

25
vs 9

178%

Q2.21

arrow
arrow

24

24
vs 25

-4%

Q3.21

arrow
arrow

25

25
vs 24

4%

Q4.21

arrow
arrow

25

25
vs 25

NA

Q1.22

arrow
arrow

23

23
vs 25

-8%

Q2.22

arrow
arrow

21

21
vs 23

-9%

Q3.22

arrow
arrow

18

18
vs 21

-14%

Q4.22

arrow
arrow

1

1
vs 18

-94%

Earnings Growth

Latest News